Results 21 to 30 of about 1,834 (164)

Informing iQOS Regulations in the United States: A Synthesis of What We Know

open access: yesSAGE Open, 2020
The tobacco industry offers various products, including heated tobacco products (HTPs). Philip Morris International’s (PMI) “iQOS” has the greatest HTP market share, as well as research on its use and impact.
Carla J. Berg   +2 more
doaj   +1 more source

Does iQOS harvest personal data from users and manipulate their tobacco habits?: A review of current evidence

open access: yesTobacco Induced Diseases, 2019
Objective To review available reports on harvesting personal data about tobacco habits from iQOS users and raise awareness of tobacco users and tobacco control community on this risk.
Krzysztof Przewozniak   +2 more
doaj   +1 more source

210Po and 210Pb content in the smoke of Heated Tobacco Products versus Conventional Cigarette smoking

open access: yesScientific Reports, 2022
210Po is a radioactive component of conventional cigarette tobacco smoke and is a recognized carcinogen. Despite the expanding market of heated tobacco products, no data are available on the activity of 210Po in the smoke of IQOS Heets cigarette.
Aurélie Berthet   +4 more
doaj   +1 more source

IQOS labelling will mislead consumers [PDF]

open access: yes, 2018
BACKGROUND: Philip Morris International (PMI) continually expands and diversifies their nicotine product portfolio, which includes IQOS, a heated tobacco product.
McKelvey, Karma   +15 more
core   +1 more source

Proximity of IQOS and JUUL points of sale to schools in Israel: a geospatial analysis

open access: yes, 2021
SIGNIFICANCE: Exploring proximity and density of heated tobacco product (HTP) and electronic nicotine delivery system (ENDS) points of sale (POS) to schools is critical for understanding youth marketing exposure and informing policy and enforcement to ...
Bar Zeev, Yael   +10 more
core   +1 more source

Perceived relative harm of heated tobacco products (IQOS), e-cigarettes, and cigarettes among adults in Canada: Findings from the ITC Project

open access: yesTobacco Induced Diseases, 2020
Introduction Tobacco companies have introduced heated tobacco products (HTPs), such as IQOS, which may compete with e-cigarettes among smokers interested in switching to potentially reduced-risk products.
Edward Sutanto   +11 more
doaj   +1 more source

Comparison of cytotoxicity of cigarette smoke extract derived from heat-not-burn and combustion cigarettes in human vascular endothelial cells

open access: yesJournal of Pharmacological Sciences, 2021
The present study compared the properties of mainstream smoke generated from heat-not-burn (HNB) cigarettes and a combustion cigarette (hi-lite™ brand).
Takahiro Horinouchi, Soichi Miwa
doaj   +1 more source

Promotion of “Heat Not Burn” Tobacco Products in Russia: New Threat to Tobacco Control

open access: yesTobacco Prevention and Cessation, 2018
Introduction Aim of Research To evaluate the promotion of (“heat not burn”) tobacco system IQOS in Russia Methods of Research The study was conducted in June-November 2017 by Confederation of Consumer Societies (KONFOP), using the “mystery shopper ...
Marina Chernova
doaj   +1 more source

Prevalence of heated tobacco product use among adolescents in Taiwan.

open access: yesPLoS ONE, 2020
ObjectiveTo determine the penetration of heated tobacco products (HTPs) into the youth market in Taiwan, with a particular focus on the correlation between IQOS use and the usage of other tobacco products.MethodsData from the 2018 Global Youth Tobacco ...
Li-Chuan Chang   +3 more
doaj   +1 more source

FDA’s reduced exposure marketing order for IQOS: why it is not a reliable global model [PDF]

open access: yes, 2021
The US Food and Drug Administration (FDA) issued orders in July 2020 authorising Philip Morris Products S.A. to market its heated tobacco product (HTP) IQOS inside the USA with claims that it reduces exposure to some dangerous substances.
Lempert, Lauren Kass   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy